Acute Effects of Tonic Motor Activation (TOMAC) on Sleep in Adults with Medication-Refractory Restless Legs Syndrome

Clicks: 1
ID: 316962
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #23 of 39 articles by views in SLEEP Advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Study Objectives Tonic motor activation (TOMAC) delivers high-frequency electrical stimulation to the common peroneal nerve to reduce restless legs syndrome (RLS) symptoms and improve subjective sleep quality. This cross-sectional analysis provides the first objective evaluation of wake-sleep transition and exploration of sleep parameter and leg movement changes following mid-sleep TOMAC sessions during polysomnography (PSG). Methods Twenty participants with medication-refractory RLS completed two PSGs and activated 30-minute TOMAC sessions as needed when awakening mid-sleep with RLS symptoms. Objective sleep parameters including sleep re-initiation latency, architecture, and hourly indices of periodic leg movements during sleep (PLMS) and PLMS associated with arousal (PLMA) were compared between sleep periods before and after activating mid-sleep TOMAC sessions. Results Sleep re-initiation occurred during the 30-minute TOMAC session for 24 of 29 (82.8%) mid-sleep sessions, with median latency of 6.7 (range=0.9-45.9) minutes following TOMAC activation. The latency from TOMAC activation to sleep re-initiation was shorter in participants who activated TOMAC within 10-minutes of awakening compared to those who waited longer (p=0.016). There was a linear increase in the proportion of delta and decrease in alpha EEG frequency-band power after activating mid-sleep TOMAC (both p<0.001), indicating the transition towards deeper sleep. Comparing sleep intervals before and after activating mid-sleep TOMAC, PLMS/hour decreased by 47.9% (p=0.042) and PLMA/hour decreased by 70.8% (p=0.004). Conclusions TOMAC was compatible with sleep; rapid sleep re-initiation and transition to deeper sleep were observed during TOMAC stimulation. This data also provide proof-of-concept evidence that PLMS may decrease following activation of mid-sleep TOMAC. Clinical Trial Details This study was preregistered on January 31, 2022 ClinicalTrials.gov with name “Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS” and number NCT05214963 at https://clinicaltrials.gov/study/NCT05214963.
Reference Key
openalex_W7164322377 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Stephanie K. Rigot, Erik K. St. Louis, Fiona C. Baker, H. Alawieh, Haramandeep Singh, Joseph Ojile, Jatin Tekchandani, Viktoriia Kolotovska, Bahman Adlou, Jonathan D. Charlesworth
Journal SLEEP Advances
Year 2026
DOI
10.1093/sleepadvances/zpag060
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.